Literature DB >> 20407980

Prenatal drug exposure: infant and toddler outcomes.

Emmalee S Bandstra1, Connie E Morrow, Elana Mansoor, Veronica H Accornero.   

Abstract

This manuscript provides an overview of the current scientific literature on the impact of maternal drug use, specifically opioids and cocaine, during pregnancy on the acute and long-term outcomes of infants and toddlers from birth through age 3 years. Emphasis with regard to opioids is placed on heroin and opioid substitutes used to treat opioid addiction, including methadone, which has long been regarded as the standard of care in pregnancy, and buprenorphine, which is increasingly being investigated and prescribed as an alternative to methadone. Controlled studies comparing methadone at high and low doses, as well as those comparing methadone with buprenorphine, are highlighted and the diagnosis and management of neonatal abstinence syndrome is discussed. Over the past two decades, attention of the scientific and lay communities has also been focused on the potential adverse effects of cocaine and crack cocaine, especially during the height of the cocaine epidemic in the United States. Herein, the findings are summarized from prospective studies comparing cocaine-exposed with non-cocaine-exposed infants and toddlers with respect to anthropometric growth, infant neurobehavior, visual and auditory function, and cognitive, motor, and language development. The potentially stigmatizing label of the so-called "crack baby" preceded the evidence now accumulating from well-designed prospective investigations that have revealed less severe sequelae in the majority of prenatally exposed infants than originally anticipated. In contrast to opioids, which may produce neonatal abstinence syndrome and infant neurobehavioral deficits, prenatal cocaine exposure appears to be associated with what has been described as statistically significant but subtle decrements in neurobehavioral, cognitive, and language function, especially when viewed in the context of other exposures and the caregiving environment which may mediate or moderate the effects. Whether these early findings may herald more significant learning and behavioral problems during school-age and adolescence when the child is inevitably confronted with increasing social and academic challenges is the subject of ongoing longitudinal research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20407980     DOI: 10.1080/10550881003684871

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  42 in total

1.  Factors associated with buprenorphine versus methadone use in pregnancy.

Authors:  Elizabeth E Krans; Debra Bogen; Gale Richardson; Seo Young Park; Shannon L Dunn; Nancy Day
Journal:  Subst Abus       Date:  2016-02-25       Impact factor: 3.716

2.  Early Intervention Referral and Enrollment Among Infants with Neonatal Abstinence Syndrome.

Authors:  Elizabeth Peacock-Chambers; JoAnna K Leyenaar; Sheila Foss; Emily Feinberg; Donna Wilson; Peter D Friedmann; Paul Visintainer; Rachana Singh
Journal:  J Dev Behav Pediatr       Date:  2019 Jul/Aug       Impact factor: 2.225

3.  Prenatal toxicology screening for substance abuse in research: codes and consequences.

Authors:  Annie J Rohan; Catherine Monk; Karen Marder; Nancy Reame
Journal:  Subst Abus       Date:  2011-07       Impact factor: 3.716

4.  Developmental Outcomes of Infants Adopted from Foster Care: Predictive Associations from Perinatal and Preplacement Risk Factors.

Authors:  Irene Tung; Allison S Christian-Brandt; Audra K Langley; Jill M Waterman
Journal:  Infancy       Date:  2019-12-23

Review 5.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

6.  Predictors of developmental status in young children living in institutional care in Kazakhstan.

Authors:  Maria G Kroupina; Liza Toemen; Musa M Aidjanov; Michael Georgieff; Mary O Hearst; John H Himes; Dana E Johnson; Bradley S Miller; Aigul M Syzdykova; Toregeldy S Sharmanov
Journal:  Matern Child Health J       Date:  2015-06

7.  Overinhibition of corticostriatal activity following prenatal cocaine exposure.

Authors:  Wengang Wang; Ioana Nitulescu; Justin S Lewis; Julia C Lemos; Ian J Bamford; Natasza M Posielski; Granville P Storey; Paul E M Phillips; Nigel S Bamford
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

8.  Should pregnant women with substance use disorders be managed differently?

Authors:  Verena Metz; Birgit Köchl; Gabriele Fischer
Journal:  Neuropsychiatry (London)       Date:  2012-01-25

Review 9.  Systematic review of prenatal cocaine exposure and adolescent development.

Authors:  Stacy Buckingham-Howes; Sarah Shafer Berger; Laura A Scaletti; Maureen M Black
Journal:  Pediatrics       Date:  2013-05-27       Impact factor: 7.124

10.  Prenatal cocaine effects on brain structure in early infancy.

Authors:  Karen Grewen; Margaret Burchinal; Clement Vachet; Sylvain Gouttard; John H Gilmore; Weili Lin; Josephine Johns; Mala Elam; Guido Gerig
Journal:  Neuroimage       Date:  2014-07-03       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.